Diaziquone for resistant multiple myeloma. Cancer and Leukemia Group B.
D000328:Adult; D000368:Aged; D001388:Aziridines / Q000009:adverse effects / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use*; D016227:Benzoquinones; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D010865:Pilot Projects; D013921:Thrombocytopenia / Q000139:chemically induced
D001388:Aziridines; D001389:Azirines; D016227:Benzoquinones; C029108:diaziquone